These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 20372798)

  • 1. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
    Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
    Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of decitabine on the expression of selected endogenous control genes in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Mol Cell Probes; 2010 Apr; 24(2):87-92. PubMed ID: 19837153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
    Hu H; Li S; Cui X; Lv X; Jiao Y; Yu F; Yao H; Song E; Chen Y; Wang M; Lin L
    J Biol Chem; 2013 Apr; 288(16):10973-85. PubMed ID: 23436656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
    Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
    Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
    Zhang YY; Tian WP; Mei M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
    Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
    Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.
    Fan J; Yin WJ; Lu JS; Wang L; Wu J; Wu FY; Di GH; Shen ZZ; Shao ZM
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):883-90. PubMed ID: 18264725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines.
    Hurtubise A; Momparler RL
    Anticancer Drugs; 2004 Feb; 15(2):161-7. PubMed ID: 15075673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
    Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
    J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
    Billam M; Sobolewski MD; Davidson NE
    Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
    Luszczek W; Cheriyath V; Mekhail TM; Borden EC
    Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
    Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
    BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.